Clinical trial
Effects of Antimuscarinic Drugs on OAB Symptoms After Insertion of Ureteral Stents
NCT01210859 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Antimuscarinic Drugs on OAB Symptoms After Insertion of Ureteral Stents
- Lead sponsor
- Meir Medical Center
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- September 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder